Reference the anomalous disclosure paragraph on Medscape relating to Peter/Thomas Kramer, I have not yet received a response to my query from Dr Robert Kennedy, the site director of Medscape, but I also emailed Thomas A. M. Kramer, who tells me that the disclosure in question relates to Peter D. Kramer and not to himself. He has contacted Dr Kennedy to ask him to correct the error.
I have been awaiting a direct response from Dr Kennedy, hoping for an explanation of how the error occurred. In reply to a second email I sent to Thomas Kramer, he told me that he had received a very brief response from Dr Kennedy saying they were aware of the problem and were fixing it. Dr Kramer added that Dr Kennedy is very involved (�stressed� is the way he put it!) at the moment with the American Psychiatric Association meetings that start on Saturday, and that he expects him to reply to my email at some point. I also asked Thomas Kramer about any pharmalogical connections he has currently, or in the past. He told me that prior to 2000 he did some sponsored research and consulting to various pharmaceutical agencies when he lived in Little Rock, Arkansas, but when he started work for the American Board of Psychiatry and Neurology in Chicago in 2000 he cut all ties to pharmacology companies. Since he left the Board in 2003 and started working for Medscape (for money � previously his writings for Medscape had been pro bono) he says he has done one talk for Abbott and a few for Pfizer. He writes: �I refuse to do any talks that I do not have complete control of the content of.� Allen Esterson Former lecturer, Science Department Southwark College, London [EMAIL PROTECTED] http://www.human-nature.com/esterson/index.html http://www.butterfliesandwheels.com/articleprint.php?num=10 --- You are currently subscribed to tips as: [EMAIL PROTECTED] To unsubscribe send a blank email to [EMAIL PROTECTED]
